11:00am Design and Evaluation of BsADCs – Key Attributes Contributing to the Efficacy & Safety of BsADC
Time: 11:00 am
day: Bispecific ADC Seminar Day
Details:
- Discussing what to benchmark BsADC candidates against when assessing preclinical efficacy
- Differences in toxicity modeling for BsADCs versus monoclonal ADCs
- Navigating what to expect when entering the clinic with a BsADC compared to a monoclonal ADC
